Skip to content

Preconceptional Thyroid Screening and Childhood Nerocognitive Function

Preconceptional Thyroid Screening and Childhood Nerocognitive Function

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01744743
Enrollment
600
Registered
2012-12-07
Start date
2011-01-31
Completion date
2015-12-31
Last updated
2012-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidism

Keywords

preconception, hypothyroidism, neurocognitive development

Brief summary

To assess the effect of universal preconception hypothyroidism for maternal pregnancy outcome, and 0-3yrs offspring neurocognitive ability and IQ score.

Detailed description

Epidemic evidence and animal studies suggested that hypothyroidism is related with maternal pregnancy outcome, offspring cognitive ability. Negro's study found improved maternal health in those screened in early trimester; while Lazarus et al. reported no significant offspring IQ score at 3yrs in universal screening in early trimester. Currently, it lacks evidence of universal pre-conception screening for maternal pregnancy outcome and offspring cognitive development, motivation ability, attention. China Governmental Health Department has included thyroid function screening into preconception in 2011. The investigators hypothesize that pre-conception effective treatment may be helpful for decrease possible negative effects on maternal and offspring health, instead of early trimester.

Interventions

PROCEDURElevothyroxine

Women with TSH≥97.5%th and/or FT4≤2.5%th will accept levothyroxine 150ug daily and follow-up every 4 weeks.

Sponsors

Shanghai Municipal Science and Technology Commission
CollaboratorOTHER_GOV
Shanghai Municipal Health Bureau
CollaboratorOTHER_GOV
Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. Preconceptional group:TSH ≥ 97.5%th and/or FT4 ≤ 2.5%th 2. age: 18-55 3. those who can obey the rules of this study and assign the consent

Exclusion criteria

1. age: less than 18 or more than 55 2. multiple pregnancy 3. thyroid tumor disease history 4. those who cannot obey the rules of this study

Design outcomes

Primary

MeasureTime frameDescription
Offspring neurocognitive assessment at 0-3 yrs3 months, 6 months, 1 year, 2 years, 3 yearsPeabody scale, Griffith scale
Offspring IQ assessment at 0-3 yrs3 months, 6 months, 1 year, 2 years, 3 yearsWechsler Preschool Intelligence Scale at 1, 2, 3-year-old

Secondary

MeasureTime frameDescription
Incidence of neonatal hypothyroid and complicationsup to 28 days of birthneonatal hypothyroid function, NICU rate, neonatal death rate

Other

MeasureTime frameDescription
Incidence of maternal complicationsup to 42 days postpartumnpreeclampsia, GDM, maternal death rate, maternal hemorrhage rate

Countries

China

Contacts

Primary ContactXiaotian Li, MD, PhD
xiaotianli555@163.com862163455050
Backup ContactQiongjie Zhou, MD
qj_zhou@163.com862163455050

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026